Login / Signup

Controlling CRISPR-Cas9 with ligand-activated and ligand-deactivated sgRNAs.

Kale KundertJames E LucasKyle E WattersChristof FellmannAndrew H NgBenjamin M HeineikeChristina M FitzsimmonsBenjamin L OakesJiuxin QuNeha PrasadOren S RosenbergDavid F SavageHana El-SamadJennifer A DoudnaTanja Kortemme
Published in: Nature communications (2019)
The CRISPR-Cas9 system provides the ability to edit, repress, activate, or mark any gene (or DNA element) by pairing of a programmable single guide RNA (sgRNA) with a complementary sequence on the DNA target. Here we present a new method for small-molecule control of CRISPR-Cas9 function through insertion of RNA aptamers into the sgRNA. We show that CRISPR-Cas9-based gene repression (CRISPRi) can be either activated or deactivated in a dose-dependent fashion over a >10-fold dynamic range in response to two different small-molecule ligands. Since our system acts directly on each target-specific sgRNA, it enables new applications that require differential and opposing temporal control of multiple genes.
Keyphrases
  • crispr cas
  • small molecule
  • genome editing
  • nucleic acid
  • genome wide
  • circulating tumor
  • genome wide identification
  • cell free
  • copy number
  • protein protein
  • single molecule
  • dna methylation
  • gene expression